Use of Multiphoton Microscopy in the Diagnosis of Cancer (MPM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by Weill Medical College of Cornell University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00652210
First received: March 31, 2008
Last updated: November 4, 2010
Last verified: November 2010

March 31, 2008
November 4, 2010
October 2007
October 2008   (final data collection date for primary outcome measure)
After several delays, the multiphoton microscope has been delivered to Weill Cornell Medical College. We have been using this time to set-up and fine tune the multiphoton microscope. As of current, no negative events have occurred. [ Time Frame: 10/14/2007 to 2/15/2008 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00652210 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Use of Multiphoton Microscopy in the Diagnosis of Cancer
Use of Multiphoton Microscopy in the Diagnosis of Cancer

Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria, we plan to develop an endoscopic bladder probe that will provide a non-invasive means to image the interior of the bladder at the cellular level, which would provide direct evidence of the presence of tumor without a biopsy. After exhibiting usefulness of MPM imaging for bladder cancer, we will look at other organs beginning with the colon.

Same as above

Interventional
Phase 1
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
  • Bladder Cancer
  • Prostate Cancer
Other: Multiphoton microscopy
Use of multiphoton microscopy to diagnose cancer
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
March 2010
October 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Anyone who presents with bladder and/or prostate cancer
Both
21 Years to 85 Years
Yes
Contact: Ming-Ming Lee, B.A. (212) 746-5467 mil2022@med.cornell.edu
United States
 
NCT00652210
0506007919
No
Douglas S. Scherr/Clinical Director of Urologic Oncology, Weill Cornell Medical College
Weill Medical College of Cornell University
Not Provided
Principal Investigator: Douglas S Scherr, M.D. Weill Medical College of Cornell University
Weill Medical College of Cornell University
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP